Generic Patanol for Seasonal Allergic Conjunctivitis Approved - Pharmacy Times
Generic Patanol for Seasonal Allergic Conjunctivitis ApprovedPharmacy TimesThe FDA has given final approval to Aurobindo Pharma Limited to manufacture and market olopatadine hydrochloride ophthalmic solution, a generic equivalent of Alcon Laboratories Inc's Patanol drops.
Novartis's Alcon Wins Bid to Block Apotex's Generic PatanolBloombergThe ruling means the order preventing Apotex from selling generic Patanol remains in effect, Eric Althoff, a spokesman for Novartis, said in a statement.
Ophthalmic Drugs Market Forecast 2016-2026MarketWatchRevenue forecasts to 2026 for 25 leading drugs- discover prospects for leading ophthalmic drugs including: Eylea, Lucentis, Avastin, Visudyne, Jetrea, Pataday, Vigamox, Patanol, TobraDex, Cravit, AzaSite, Acular, Lumigan and Ganfort, Xalatan/Xalacom, .
Commentary on Current Trends in Rising Drug Costs and Reimbursement Below Cost - Managed Care magazine
Commentary on Current Trends in Rising Drug Costs and Reimbursement Below CostManaged Care magazinePurpose: To quantify prescription drug price increases over a span of 3 years (2012–2015), as well as extrapolate current reimbursement rates expected by independent retail pharmacies.
Novartis (NVS) Q1 Earnings Miss; Gleevec Hit by Generics - Zacks.com
Novartis (NVS) Q1 Earnings Miss; Gleevec Hit by GenericsZacks.